Takeda at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Takeda takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8023. Its program centres on metastatic colorectal cancer that has stopped responding to chemotherapy. The discussion works through the real-world treatment decisions clinicians face for these patients.

OrganizationESMO 2026 Attendance
takeda.com
Large pharmaExhibitor
Japanese pharmaceutical company with oncology medicines for blood cancers and solid tumours, including lung cancer.
Booth
Exhibiting at Booth 8023
Satellite
Mon Oct 26
13:00–14:30
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC
Sponsored session · with Hospital Universitario de Navarra
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Takeda

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction